The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADAPTIMMUNE THERAPEUTICS PLC | SPONS ADR | 00653A107 | 550 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
AGENUS | COM | 00847G705 | 3,831 | 443,868 | SH | SOLE | 443,868 | 0 | 0 | ||
AGILE THERAPEUTICS | COM | 00847L100 | 1,104 | 128,566 | SH | SOLE | 128,566 | 0 | 0 | ||
ALCOBRA SHS | SHS | M223P109 | 458 | 70,039 | SH | SOLE | 70,039 | 0 | 0 | ||
ALIMERA SCIENCES | COM | 016259103 | 4,492 | 974,318 | SH | SOLE | 974,318 | 0 | 0 | ||
AMICUS THERAPEUTICS | COM | 03152W109 | 25,116 | 1,775,000 | SH | SOLE | 1,775,000 | 0 | 0 | ||
APPLIED GENETIC TECHNOL | COM | 03820J100 | 11,474 | 748,000 | SH | SOLE | 748,000 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONS ADR | 04351P101 | 7,458 | 421,851 | SH | SOLE | 421,851 | 0 | 0 | ||
AURINIA PHARMACEUTICALS | COM | 05156V102 | 1,585 | 524,751 | SH | SOLE | 524,751 | 0 | 0 | ||
AVID TECHNOLOGY | COM | 05367P100 | 3,068 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
AXOVANT SCIENCES | COM | G0750W104 | 3,465 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
BIODEL | COM | 09064M204 | 2,973 | 2,886,731 | SH | SOLE | 2,886,731 | 0 | 0 | ||
BIOTELEMETRY | COM | 090672106 | 6,224 | 660,000 | SH | SOLE | 660,000 | 0 | 0 | ||
BUILD A BEAR WORKSHOP | COM | 120076104 | 3,198 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CARDICA | COM | 14141R101 | 923 | 1,849,436 | SH | SOLE | 1,849,436 | 0 | 0 | ||
CAS MED SYS PAR $0.004 | COM PAR | 124769209 | 3,015 | 2,355,355 | SH | SOLE | 2,355,355 | 0 | 0 | ||
CEMPRA | COM | 15130J109 | 515 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
CHEMBIO DIAGNOSTICS | COM | 163572209 | 638 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
CIDARA THERAPEUTICS | COM | 171757107 | 1,823 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
COLLEGIUM PHARMACEUTICAL | COM | 19459J104 | 2,319 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
COMBIMATRIX CORPORATION | COM | 20009T303 | 1,417 | 880,244 | SH | SOLE | 880,244 | 0 | 0 | ||
CUTERA | COM | 232109108 | 1,161 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
CYNAPSUS THERAPEUTICS INC | COM PAR NO PAR | 23257Y859 | 2,763 | 169,616 | SH | SOLE | 169,616 | 0 | 0 | ||
FLEX PHARMA | COM | 33938A105 | 1,526 | 88,716 | SH | SOLE | 88,716 | 0 | 0 | ||
FOAMIX PHARMACEUTICALS SHS | SHS | M46135105 | 308 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
HISTOGENICS | COM | 43358V109 | 796 | 123,249 | SH | SOLE | 123,249 | 0 | 0 | ||
HOMEAWAY | COM | 43739Q100 | 778 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
HUMANA | COM | 444859102 | 1,148 | 6,000 | SH | SOLE | 6,000 | 0 | 0 | ||
IGI LABS | COM | 449575109 | 2,917 | 462,944 | SH | SOLE | 462,944 | 0 | 0 | ||
INNOCOLL AG SPONSORED ADR | SPONS ADR | 45780Q103 | 3,472 | 237,287 | SH | SOLE | 237,287 | 0 | 0 | ||
IRIDEX | COM | 462684101 | 2,578 | 312,450 | SH | SOLE | 312,450 | 0 | 0 | ||
ISHARES TR | RUSSELL 2000 ETF | 464287655 | 8,739 | 70,000 | SH | Put | SOLE | 70,000 | 0 | 0 | |
KINDRED BIOSCIENCES | COM | 494577109 | 341 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
LEMAITRE VASCULAR | COM | 525558201 | 3,015 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
LION BIOTECHNOLOGIES | COM | 53619R102 | 8,125 | 886,000 | SH | SOLE | 886,000 | 0 | 0 | ||
MOL GLOBAL SPONSORED ADR | SPONS ADR | 60845Q105 | 226 | 147,912 | SH | SOLE | 147,912 | 0 | 0 | ||
NEURODERM ORD SHS | ORD SHS | M74231107 | 4,605 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
NIC | COM | 62914B100 | 1,280 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
ONCOTHYREON | COM | 682324108 | 2,506 | 670,000 | SH | SOLE | 670,000 | 0 | 0 | ||
OTONOMY | COM | 68906L105 | 1,228 | 53,400 | SH | SOLE | 53,400 | 0 | 0 | ||
OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 2,738 | 197,680 | SH | SOLE | 197,680 | 0 | 0 | ||
RR MEDIA SHS | SHS | M8183P102 | 3,083 | 410,000 | SH | SOLE | 410,000 | 0 | 0 | ||
SAGENT PHARMACEUTICALS | COM | 786692103 | 681 | 28,000 | SH | SOLE | 28,000 | 0 | 0 | ||
SEMLER SCIENTIFIC | COM | 81684M104 | 267 | 80,935 | SH | SOLE | 80,935 | 0 | 0 | ||
SORRENTO THERAPEUTICS | COM | 83587F202 | 3,743 | 212,402 | SH | SOLE | 212,402 | 0 | 0 | ||
SPECTRANETICS | COM | 84760C107 | 5,753 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
SUNSHINE HEART INC | COM | 86782U106 | 207 | 60,000 | SH | Put | SOLE | 60,000 | 0 | 0 | |
VERACYTE | COM | 92337F107 | 8,891 | 798,100 | SH | SOLE | 798,100 | 0 | 0 | ||
VERSARTIS | COM | 92529L102 | 761 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ZAFGEN | COM | 98885E103 | 1,832 | 52,900 | SH | SOLE | 52,900 | 0 | 0 | ||
ZOSANO PHARMA | COM | 98979H103 | 632 | 87,189 | SH | SOLE | 87,189 | 0 | 0 |